Shinomiya / Shimada Applications of Cell Culture

1. Auflage 2025
ISBN: 978-981-950587-6
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 184 Seiten

Reihe: Biomedical and Life Sciences

This book explores recent advances in the application of cell culture for experimental and clinical use. It addresses fundamental issues such as cell line misidentification and offers practical tips for its prevention. It also highlights the latest trends in human cell research for establishing disease models, drug discovery, and new therapeutic trials.

The chapters provide a comprehensive guide to the establishment, maintenance, and passage methods of established cell lines, based on the history of cell line establishment. The book also details research activities and effective examples of clinical use of these established cell lines. In particular, dental pulp-derived stem cells are utilized as an example of primary culture, highlighting important perspectives in establishing clinical-grade standards for regenerative therapy and personalized medicine. It also covers innovative culture techniques of respiratory epithelial cells and their application to clinical studies. The book addresses the issue of cell line misidentification and clarifies the methods for determining the correct cell lines. Recent efforts to isolate and culture cells from trace amounts of clinical samples are also discussed, offering technical insights and outlining challenges for future applications of circulating tumor cells. Furthermore, it provides an overview of organoid culture and its applications in cancer research. The latter part of the book focuses on limitations of long-established cell lines suffering from genomic drift, a lack of clinical annotation, and the underrepresentation of rare cancers. Also, it describes the critical role of cancer cell lines in advancing rare-cancer research. The final chapter introduces research examples using iPS cells and AI in the field of neurodegenerative diseases, focusing on reprogramming technology.

This book is intended for researchers, clinicians and students in the fields of cancer research, cell physiology, drug discovery and stem/iPS cell research.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Shinomiya, Nariyoshi

Shimada, Yutaka

Inhaltsverzeichnis

1 History of Cell Line Establishment and Application.- 2 Tips for How to Establish Cell Lines.- 3 Maintenance, Appropriate Passage, and Differentiation Induction of Established Cells.- 4 Effective Use of Established Cells for Research and Clinical Applications.- 5 Prevention of Misrecognition of Cell Lines / Determination Methods for Correct Cell Lines.-6 Culture of the Circulating Tumor Cell.- 7 Culture and Handling of Patient-Derived Cells –Through the Organoid Culture and its Analysis.- 8 Cell Line Establishment and Passage by Xenograft.- 9 Cell Lines for the Analysis of Rare Diseases.- 10 Diagnostic application and drug discovery using Stem Cells and iPS Cells.

Über Autor(innen)

Nariyoshi SHINOMIYA, M.D., Ph.D., was a professor and the president of the National Defense Medical College (NDMC) until 2024. Currently, he is Professor Emeritus at the NDMC and a visiting senior researcher at the National Institute of Infectious Diseases, Japan Institute for Health Security. His areas of expertise are microbiology/immunology and molecular oncology. His research interests include radiosensitivity and apoptosis of tumor cells, Met tyrosine kinase function and regulation of tumor growth, etc. He served as President of the Japan Human Cell Society from 2015 to 2023.

 Yutaka SHIMADA, M.D., Ph.D., FACS, has been a professor at the Department of Nanobio Drug Discovery at Kyoto University. He established more than 60 human esophageal cancer cell lines (KYSE-series) and 10 pancreatic cancer cell lines (KMP-series, TYPK-series). He has also established several gallbladder and bile duct cancer cell lines. His recent research focuses on establishing a standard method for culturing circulating tumor cells. He served as Vice President of the Japan Human Cell Society from 2015 to 2023.